Alzamend Neuro (ALZN) Non-Current Assets (2022 - 2026)
Alzamend Neuro's Non-Current Assets came in at $287,181 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 27.8% from $397,921 a year earlier and down 8.8% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro's Non-Current Assets was $314,866, down 26.0% from FY2025.
- Non-Current Assets carries a four-year compound annual growth rate of 32.3% (FY2022 to FY2026).
- Going back by fiscal year, Non-Current Assets was $425,606 in FY2025 (+141.3%), $176,346 in FY2024 (+120.9%), $79,843 in FY2023 (-22.4%) and $102,909 in FY2022.
- The fiscal Q1 2027 figure represents the lowest quarterly Non-Current Assets since fiscal Q3 2025.
- Year-over-year, Non-Current Assets increased in six of the last eight quarters, with growth averaging 36.0%.
- The fastest year-over-year change in Non-Current Assets over five years came in fiscal Q4 2025 (growth of 141.3%), and the weakest in fiscal Q1 2027 (a decline of 27.8%).
- Business Quant data shows ALZN's Non-Current Assets at $314,866 (Q4 2026), $342,551 (Q3 2026) and $370,236 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | 287,181.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 287,181.00 |
| Apr 30, 2026 | 314,866.00 |
| Jan 31, 2026 | 342,551.00 |
| Oct 31, 2025 | 370,236.00 |
| Jul 31, 2025 | 397,921.00 |
| Apr 30, 2025 | 425,606.00 |
| Jan 31, 2025 | 228,291.00 |
| Oct 31, 2024 | 240,976.00 |
| Jul 31, 2024 | 253,661.00 |
| Apr 30, 2024 | 176,346.00 |
| Jan 31, 2024 | 189,031.00 |
| Oct 31, 2023 | 201,716.00 |
| Jul 31, 2023 | 214,401.00 |
| Apr 30, 2023 | 79,843.00 |
| Jan 31, 2023 | 85,166.00 |
| Oct 31, 2022 | 90,489.00 |
| Jul 31, 2022 | 95,812.00 |
| Apr 30, 2022 | 102,909.00 |
API Access
Alzamend Neuro Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();